SOURCE-LINKED INTELLIGENCE
A revolutionary cell programming platform based on the targeted nano-delivery of a transposon gene editing system
ug product characterization insights. SINTEF adds crucial know-how on bulk analysis of Targeted Nanoparticles, and is closely involved in regulatory standards for nucleic acid therapeutics. QSAR uses machine learning to predict nanoparticle performance and minimize experimental work. Cell therapy, cell biology, microbiology, technology commercialization, nanomedicine, in vivo gene editing, lipid nanoparticles, drug development, B-cell malignancies, mass spectrometry
Read original source ↗ Open in workspace
- recordType
- award
- status
- SIGNED
- region
- EU
- value
- 2988377.7
- unit
- EUR
Evidence & attribution
European Commission, CORDIS Horizon Europe project dataset. Metadata adapted.
License: CORDIS reuse policy
First collected: 2026-09-20T01:21:06.728Z. This is not the publication date.